News
Biogen developing test to detect risk from MS drug
August 24, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | CommentsBiogen Idec has reported promising early data for a test to help determine which patients taking its multiple sclerosis drug, Tysabri, are at greatest risk for developing a rare but serious brain infection.
Bernard Gordon launches medical imaging startup Photo Diagnostics
August 24, 2010 7:32 am | by Mass High Tech: The Journal of New England Technology | CommentsBernard Gordon, founder and former CEO of Analogic Corp. and co-founder of NeuroLogica Corp., has started another company in Danvers-based Photo Diagnostic Systems Inc., and he's invested $5 million as the first institutional funding for the medical imaging startup.
Medtronic cuts 2011 guidance on weaker demand
August 24, 2010 6:45 am | by The Associated Press | CommentsMedtronic Inc., the world's largest medical device maker, reported fiscal first-quarter earnings Tuesday in line with Wall Street expectations, but weaker global demand for medical implants forced the company to slash 2011 earnings expectations.The Minneapolis-based company reported...
Made in America Will Go Away without Investment in STEM-based Education
August 24, 2010 6:36 am | by Society of Manufacturing Engineers | CommentsDEARBORN, Mich., August 23, 2010 - The tagline “Made in America†will go away without increasing investment in STEM-based education. As skilled labor shortages continue to hold back various sectors of U.S. manufacturing, national organizations are looking at their investment...
New Roche deal could net Aileron $1.1B
August 24, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | CommentsAileron Therapeutics Inc., a Cambridge biotech focused on protein-based treatments, has entered into a development deal with Swiss pharmaceutical giant Roche that could bring as much as $1.1 billion to Aileron.
Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
August 24, 2010 6:35 am | by Bio-Medicine.Org | CommentsNEW YORK, Aug. 24 /- Regenicin, Inc. (OTC Bulletin Board: WDSTD ), a clinical-stage biotechnology company, announced today that Dr. Joseph Rubinfeld, one of the four original founders of Amgen, Inc., has agreed to join the company's board of directors. Dr. Rubinfeld will be instrumental...
Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market
August 24, 2010 6:35 am | by Bio-Medicine.Org | CommentsEXTON, Pa., Aug. 24 /- BioTrends Research Group, Inc. recently published its TreatmentTrends®: Vascular Access report . This report is based on online survey results from over 150 physicians (general nephrologists, surgeons, interventional radiologists and interventional...
Award-Winning U.S. Talk Show Host Montel Williams Joins Rex Bionics New International Advisory Board
August 24, 2010 6:34 am | by Bio-Medicine.Org | CommentsNORTH HARBOUR, New Zealand, Aug. 24 /- Rex Bionics Ltd., the company developing a robotic exoskeleton enabling wheelchair users to walk, announced formation of an International Advisory Board that includes Emmy Award-winning U.S. talk show host Montel Williams . Also named to the...
Echo Therapeutics Announces Successful Completion of Clinical Trial for Preludeâ„¢ SkinPrep System and 4% Lidocaine Cream
August 24, 2010 6:34 am | by Bio-Medicine.Org | CommentsFRANKLIN, Mass., Aug. 24 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphonyâ„¢ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Preludeâ„¢ SkinPrep System for transdermal drug...
+PLUSPAK (polymer bottle) Packaging Receives GE's Distinguished ecomagination(SM) Approval
August 24, 2010 6:33 am | by Bio-Medicine.Org | CommentsPRINCETON, N.J., Aug. 24 /- GE Healthcare is proud to announce that + PLUS PAK (polymer bottle) packaging is now included in the company's ecomagination(SM) campaign. + PLUS PAK, an innovative packaging container for contrast media, offers significant advantages over traditional...
Zacks Rates CardioGenics 'Outperform' With Six-Month Target of $1.22
August 24, 2010 6:33 am | by Bio-Medicine.Org | CommentsMISSISSAUGA, Ontario , Aug. 24 /- Zacks Equity Research initiated research coverage on CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH ) with a six-month target price of $1.22 per share. The 25-page Zacks report, which gives the company an investment rating of 'Outperform', details...
Medtronic 1Q net income climbs to $830 million
August 24, 2010 3:45 am | by The Associated Press | CommentsMedical device maker Medtronic says its first-quarter earnings jumped to $830 million, but revenue fell in a soft global health care market.The world's largest medical-device company says it earned 76 cents per share in the three months that ended July 30. That compares to net income of $445...
ORNL scientists help explain graphene mystery
August 24, 2010 1:33 am | by I-Micronews | CommentsA research team led by ORNL's Bobby Sumpter, Vincent Meunier and Eduardo Cruz-Silva has discovered how loops develop in graphene, an electrically conductive high-strength low-weight material that resembles an atomic-scale honeycomb.
Fortis Hospitals India Does Asia's First Custom Fit Knee Replacement Surgery
August 24, 2010 1:32 am | by Bio-Medicine.Org | CommentsFortis Hospitals India Does Asia's First Custom Fit Knee Replacement Surgery -- BANGALORE, India, August 24, 2010 /-
Ex post evaluation of FP6 (NMP) at strategic level available now
August 24, 2010 12:32 am | by I-Micronews | CommentsWas the thematic priority ?Nano-technologies and nano-sciences, knowledge-based multifunctional materials, and new production processes and devices? (NMP) of the Sixth Framework Programme (FP6) successful in the context of the objectives of the Lisbon Agenda and the European Research Area?
